RPg Family Wealth Advisory LLC Takes Position in iShares Biotechnology ETF (NASDAQ:IBB)

RPg Family Wealth Advisory LLC purchased a new stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 472 shares of the financial services provider’s stock, valued at approximately $69,000.

A number of other large investors have also added to or reduced their stakes in IBB. Blue Fin Capital Inc. grew its stake in shares of iShares Biotechnology ETF by 0.7% in the 2nd quarter. Blue Fin Capital Inc. now owns 10,516 shares of the financial services provider’s stock valued at $1,443,000 after buying an additional 74 shares during the period. Security National Bank of SO Dak lifted its position in shares of iShares Biotechnology ETF by 0.7% during the second quarter. Security National Bank of SO Dak now owns 10,461 shares of the financial services provider’s stock worth $1,436,000 after purchasing an additional 75 shares in the last quarter. SPC Financial Inc. lifted its holdings in iShares Biotechnology ETF by 2.4% during the 3rd quarter. SPC Financial Inc. now owns 3,265 shares of the financial services provider’s stock worth $475,000 after buying an additional 75 shares in the last quarter. Werba Rubin Papier Wealth Management boosted its holdings in iShares Biotechnology ETF by 2.7% in the third quarter. Werba Rubin Papier Wealth Management now owns 2,918 shares of the financial services provider’s stock valued at $425,000 after purchasing an additional 76 shares during the period. Finally, Main Street Financial Solutions LLC grew its position in shares of iShares Biotechnology ETF by 1.0% during the second quarter. Main Street Financial Solutions LLC now owns 8,002 shares of the financial services provider’s stock worth $1,098,000 after buying an additional 82 shares in the last quarter. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Up 1.0 %

Shares of IBB stock opened at $141.59 on Thursday. The firm has a fifty day moving average price of $143.12 and a 200 day moving average price of $141.97. iShares Biotechnology ETF has a 12 month low of $117.28 and a 12 month high of $150.57.

iShares Biotechnology ETF Announces Dividend

The company also recently disclosed a dividend, which was paid on Monday, September 30th. Stockholders of record on Wednesday, September 25th were issued a $0.2005 dividend. The ex-dividend date was Wednesday, September 25th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.